N/A N=40 Randomized Quadruple-blind Health Services Research

Efficacy of Preoperative Pectoral Nerve Block for Intraoperative Opioid Sparing Effect and Postoperative Analgesia

Breast Cancer

Bottom Line

View on ClinicalTrials.gov: NCT03210220 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2019

Primary outcome: Primary: Intraoperative Remifentanil Consumption — 6.75; 10.12 μg/kg/h

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Pecs II block (Procedure)
Age: Adult, Older Adult · 20+ yrs
Sex: Female
Sponsor: Gachon University Gil Medical Center
Primary completion: Dec 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Intraoperative Remifentanil Consumption	6.75; 10.12	—

Summary

The purpose of this study is to determine whether pectoral nerves blocks（PECS） would reduces the opioid consumption during the surgery and postoperative pain after breast cancer surgery.

Eligibility Criteria

Inclusion Criteria

American Society of Anesthesiologists( ASA) I or II Scheduled for breast cancer surgery

Exclusion Criteria

Sensitivity to local anesthetic, Bleeding disorders , Receiving anticoagulant, Body mass index (BMI) > 35/kg/m2 , Spine or chest wall deformity , Pregnancy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03210220). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.